NCT03280537: A reported trial by Hoffmann-La Roche
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03280537 |
|---|---|
| Title | A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Clinical Trial of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 21, 2017 |
| Completion date | March 7, 2019 |
| Required reporting date | March 6, 2020, midnight |
| Actual reporting date | Feb. 14, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 15, 2025 |
| Days late | None |